Capromorelin is a synthetic peptide drug that acts as a growth hormone releasing hormone (GHRH) agonist. It is used to treat canine and feline growth hormone deficiency or as an appetite stimulant in cats. Capromorelin stimulates the release of growth hormone from the pituitary gland, thereby increasing the levels of insulin-like growth factor 1 (IGF-1) in the blood. This, in turn, helps to improve the growth and development of animals. Capromorelin may also help to improve lean body mass and reduce fat mass in animals.
Capromorelin, sold under the brand names Entyce and Elura, is a medication used for the management of weight loss in cats and dogs. It is a ghrelin receptor agonist, which means it mimics the effects of the hormone ghrelin, which stimulates appetite.
Capromorelin is available in an oral liquid solution that is given by mouth. The medication is typically given once a day, with or without food.
Common side effects of capromorelin can include vomiting, diarrhea, and loss of coordination. Capromorelin can also interact with other medications, so it is important to tell your veterinarian about all of the medications your pet is taking before starting capromorelin.